¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) Á¦72Â÷ ´ëÇѾฮÇÐȸ Ãß°èÇмú´ëȸ : 2020-11-12

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) Á¦72Â÷ ´ëÇѾฮÇÐȸ Ãß°èÇмú´ëȸ : 2020-11-12
±³À°ÀÏÀÚ : 2020-11-12
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°(½Ç½Ã°£ È­»ó °­ÀÇ)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) Á¦72Â÷ ´ëÇѾฮÇÐȸ Ãß°èÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇѾฮÇÐȸ
´ã´çÀÚ : À庴ȣ 
¿¬¶ôó : 02-326-0370  
À̸ÞÀÏ : head@kosphar.org      
±³À°Á¾·ù : ¾à¸®ÇР     
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ´ëÀü±¤¿ª½Ã
±³À°½Ã°£ : 7 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 220,000¿ø      
ºñ°í ÆòÀÇ¿ø, Á¤È¸¿ø: 150,000¿ø ÁØȸ¿ø: 80,000¿ø,ºñȸ¿ø: 220,000¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 12ÀÏ  09:30~09:50 Molecular and Cellular Mechanisms in the Pathogenesis of Chronic Traumatic Encephalopathy (CTE)  ·ùÈÆ(KIST) 
±³À°½Ã°£ 11¿ù 12ÀÏ  09:50~10:10 Lipocalin-2 in the secondary brain injury  ¼®°æÈ£(°æºÏ´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  10:10~10:30 Cerebrovascular recovery after stroke via Plexin-D1 signaling activation  ¿À¿øÁ¾(Çѱ¹³ú¿¬±¸¿ø) 
±³À°½Ã°£ 11¿ù 12ÀÏ  10:30~10:50 Caveolin-1 target microRNA-X attenuates blood-brain injury after cerebral ischemia  ±èÇü¼®(Àü³²´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  09:30~09:50 CTCF-mediated Genomic Effects of BART Region on Epstein-Barr virus 3D Chromatin Structure  °­È¿Á¤(°æºÏ´ë ¾à´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  09:50~10:10 Application of nanobiotechnology for diagnosis and prevention against spillover viral infections Disease X  ¼Û´ë¼·(°í·Á´ë ¾à´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  10:10~10:30 Identification of Antiviral Drug Candidates against SARS-CoV-2 FDA-Approved Drugs  ±è½ÂÅÃ(Çѱ¹ ÆĽºÅ𸣿¬±¸¼Ò) 
±³À°½Ã°£ 11¿ù 12ÀÏ  10:30~10:50 Development of Antiviral Agents: Influenza, Zika and Coronavirus  ±èÁ¤±â(°í·Á´ë ¾à´ë) 
Åä·Ð 11¿ù 12ÀÏ  10:50~11:10 ÁúÀÇ ¹× ÀÀ´ä  () 
È޽Ġ11¿ù 12ÀÏ  11:10~11:30 Coffee Break  () 
±³À°½Ã°£ 11¿ù 12ÀÏ  11:30~12:20 Smart Mouse Model for Precision Medicine  ¼ºÁ¦°æ(¼­¿ï´ë) 
½Ä»ç 11¿ù 12ÀÏ  12:20~13:20 Á߽Ġ () 
±âŸ 11¿ù 12ÀÏ  13:20~14:20 Æ÷½ºÅÍ ¼¼¼Ç  () 
±³À°½Ã°£ 11¿ù 12ÀÏ  14:20~14:40 Molecular deconvolution identifies &quotmesenchymal-ness  Á¤ÀçÈ£(¿¬¼¼´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  14:40~15:00 Immunotherapy for complicated pregnancy associated and cellular immune abnormality  À̼º±â(°Ç¾ç´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  15:00~15:20 Leukocyte Specific Protein (LSP)-1 Regulation of Lymphocyte Functions  ±è¿Ï¿í(°¡Å縯´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  15:20~15:40 Translational approaches discovery to clinical proof of concept  ÀÓµ¿¼®(°¡Å縯´ë ÀÇ´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  14:20~14:40 Data Driven Drug Discovery Research Platform at Korea Chemical Bank  À̼±°æ(È­Çבּ¸¿ø) 
±³À°½Ã°£ 11¿ù 12ÀÏ  14:40~15:00 Induced Pluripotent Stem Cell in Disease Modelling and Drug Screening Platform  ÀÌÀçö(¼º±Õ°ü´ë ¾à´ë) 
±³À°½Ã°£ 11¿ù 12ÀÏ  15:00~15:20 Silicon neural probe for modulation and measurement of neural activities in vivo and in vitro  Á¶ÀÏÁÖ(KIST) 
±³À°½Ã°£ 11¿ù 12ÀÏ  15:20~15:40 Long-term 3D culture of primary hepatocyte in nanofibrous membrane  °ûÁ¾¿µ(¾ÆÁÖ´ë ÀÇ´ë) 
Åä·Ð 11¿ù 12ÀÏ  15:40~17:00 ÁúÀÇ ¹× ÀÀ´ä  () 
±âŸ 11¿ù 12ÀÏ  16:00~16:30 ½Ã»ó½Ä - Æóȸ½Ä  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) Á¦72Â÷ ´ëÇѾฮÇÐȸ Ãß°èÇмú´ëȸ : 2020-11-12""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ÀÇ·á À±¸®ÀÇ ÀÌÇØ : 2020-11-12
´ÙÀ½±Û ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ ÃæºÏÁöȸ ¿¬¼ö°­Á : 2020-11-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20910 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 64 2024-05-28
20909 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 61 2024-05-28
20908 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 73 2024-05-28
20907 ¼­¿ï 2024³â Á¦14ȸ °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú ¿¬¼ö°­Á : 2024-07-07 0 58 2024-05-28
20906 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¤Çü¿Ü°ú 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-07-07 0 41 2024-05-28
20905 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 28 2024-05-28
20904 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 29 2024-05-28
20903 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 64 2024-05-28
20902 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 27 2024-05-28
20901 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 45 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 39 2024-05-28
20899 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 19 2024-05-28
20898 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 41 2024-05-28
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 32 2024-05-28
20896 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 54 2024-05-28
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷